These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Redox-responsive, reversibly-crosslinked thiolated cationic helical polypeptides for efficient siRNA encapsulation and delivery. Zheng N; Song Z; Liu Y; Zhang R; Zhang R; Yao C; Uckun FM; Yin L; Cheng J J Control Release; 2015 May; 205():231-9. PubMed ID: 25683619 [TBL] [Abstract][Full Text] [Related]
10. Twin disulfides as opportunity for improving stability and transfection efficiency of oligoaminoethane polyplexes. Klein PM; Müller K; Gutmann C; Kos P; Krhac Levacic A; Edinger D; Höhn M; Leroux JC; Gauthier MA; Wagner E J Control Release; 2015 May; 205():109-19. PubMed ID: 25553827 [TBL] [Abstract][Full Text] [Related]
11. Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes. Wang Y; Li J; Chen Y; Oupický D Biomater Sci; 2015 Jul; 3(7):1114-23. PubMed ID: 26146552 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Application of Peptide-siRNA Nanoparticles from Disulfide-Constrained Cyclic Amphipathic Peptides for the Functional Delivery of Therapeutic Oligonucleotides to the Lung. Welch JJ; Dean DA; Nilsson BL Methods Mol Biol; 2021; 2208():49-67. PubMed ID: 32856255 [TBL] [Abstract][Full Text] [Related]
13. Recent progress in chemically modified siRNAs. Gaglione M; Messere A Mini Rev Med Chem; 2010 Jun; 10(7):578-95. PubMed ID: 20500149 [TBL] [Abstract][Full Text] [Related]
14. Chemical modification: the key to clinical application of RNA interference? Corey DR J Clin Invest; 2007 Dec; 117(12):3615-22. PubMed ID: 18060019 [TBL] [Abstract][Full Text] [Related]
15. Covalent conjugation of oligonucleotides with cell-targeting ligands. Alam MR; Ming X; Nakagawa O; Jin J; Juliano RL Bioorg Med Chem; 2013 Oct; 21(20):6217-23. PubMed ID: 23777829 [TBL] [Abstract][Full Text] [Related]
16. Chemical and structural modifications of RNAi therapeutics. Ku SH; Jo SD; Lee YK; Kim K; Kim SH Adv Drug Deliv Rev; 2016 Sep; 104():16-28. PubMed ID: 26549145 [TBL] [Abstract][Full Text] [Related]
17. Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors. Oe Y; Christie RJ; Naito M; Low SA; Fukushima S; Toh K; Miura Y; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K Biomaterials; 2014 Sep; 35(27):7887-95. PubMed ID: 24930854 [TBL] [Abstract][Full Text] [Related]
18. Modification of the siRNA passenger strand by 5-nitroindole dramatically reduces its off-target effects. Zhang J; Zheng J; Lu C; Du Q; Liang Z; Xi Z Chembiochem; 2012 Sep; 13(13):1940-5. PubMed ID: 22887813 [TBL] [Abstract][Full Text] [Related]
19. Effect of surface properties on liposomal siRNA delivery. Xia Y; Tian J; Chen X Biomaterials; 2016 Feb; 79():56-68. PubMed ID: 26695117 [TBL] [Abstract][Full Text] [Related]
20. siRNA stabilization prolongs gene knockdown in primary T lymphocytes. Mantei A; Rutz S; Janke M; Kirchhoff D; Jung U; Patzel V; Vogel U; Rudel T; Andreou I; Weber M; Scheffold A Eur J Immunol; 2008 Sep; 38(9):2616-25. PubMed ID: 18792414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]